Company also announces initiation of BEACON clinical study of LYR-220 in previously operated chronic rhinosinusitis patients LYR-210 and LYR-220 are designed to complement each other in addressing the broad spectrum of CRS patients treated by ENT Physicians WATERTOWN, Mass. , Jan.